Drug Trial Radar · NCT07625215
A Study to Test How Well BAY 3670549 Works and How Safe it is in Patients With Atrial Fibrillation
Last checked: Nov 20, 2026Latest source record: Oct 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
360
Planned (sponsor's estimate)
Start
Sep 1, 2026
Primary completion
May 16, 2030
Study completion May 16, 2030
Sponsor
- Lead sponsor
- BayerBayer (BAYRY)
- Sponsor type
- Industry
- First posted
- Jun 4, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main goal of this study is to find out how well BAY 3670549 works, how safe it is, how well people can tolerate it, and how the body handles the medicine. The study will compare BAY 3670549 to a placebo (a dummy treatment with no active medicine) in people with AF who need a treatment called electrical cardioversion. Electrical cardioversion is a procedure that helps the heart return to a normal rhythm. In this study, each participant will get a single intravenous (IV) infusion of either BAY 3670549 or a placebo. Participants will then be observed to see whether the heart rhythm returns to a normal rhythm. If it does not, electrical cardioversion can still be performed as planned. The study will look at how many participants return from AF to a normal rhythm, without needing electrical cardioversion and how long it takes. It will also show how many participants experience medical problems after treatment and how BAY 3670549 move into, through and out of the participants' body. The total duration of the study for an individual participant may be up two months. The findings from this study may contribute to the development of a new treatment option for people with AF.
Conditions
- Atrial Fibrillation
Interventions
BAY 3670549Drug
intravenous (IV) treatment
PlaceboOther
intravenous (IV) treatment
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants with conversion from atrial fibrillation (AF) to sinus rhythm (SR), sustained for ≥1 minute, within 3 hours after start of study intervention administration, and prior to use of rescue therapy or other SoC for cardioversionTime frame: Up to 3 hours after start of administration of study intervention
Locations
30 sites in 8 countries. Site status is shown where the registry gives one.
UCSF Advanced Heart Failure Comprehensive Care Center
San Francisco, California · Withdrawn
UCHealth University of Colorado Hospital - Cardiology
Aurora, Colorado · Not yet recruiting
Massachusetts General Hospital - Cardiology
Boston, Massachusetts · Not yet recruiting
Henry Ford Hospital - Cardiology
Detroit, Michigan · Recruiting
M Health Fairview Heart Clinic - Maplewood
Maplewood, Minnesota · Withdrawn
Duke University Hospital - Cardiology
Durham, North Carolina · Not yet recruiting
Texas Health Heart and Vascular Specialists - Fort Worth
Fort Worth, Texas · Not yet recruiting
CHRISTUS Trinity | Mother Frances Louis and Peaches Owen Heart Hospital - Electrophysiology Clinic
Tyler, Texas · Not yet recruiting
UZ Leuven Gasthuisberg - Cardiology diseases department
Leuven, Flemish Brabant, Belgium · Recruiting
Jessa Ziekenhuis | Hartcentrum Hasselt
Hasselt, Limburg, Belgium · Not yet recruiting
AZ Delta | Clinical Trial Center - Cardiology
Roeselare, West Flanders, Belgium · Not yet recruiting
University Multiprofile Hospital For Active Treatment Sveti Georgi' - EAD Department of Intensive Cardiology"
Plovdiv, Plovdiv Province, Bulgaria · Not yet recruiting
Multiprofile Hospital for Active Treatment Knyaginya Klementina Sofia EAD | Cardiology Department
Sofia, Sofia City Province, Bulgaria · Not yet recruiting
University Hospital for Active Treatment Tsaritsa Joanna - ISUL | Cardiology Clinic
Sofia, Sofia City Province, Bulgaria · Recruiting
Multiprofile Hospital for Active Treatment Dr. Stefan Cherkezov | Base 1 - Cardiology Department
Veliko Tarnovo, Veliko Tarnovo Province, Bulgaria · Recruiting
Medizinische Hochschule Hannover|Kardiologie und Angiologie
Hanover, Lower Saxony, Germany · Not yet recruiting
Herz-und Diabeteszentrum NRW|Elektrophysiologie/Rhythmologie
Bad Oeynhausen, North Rhine-Westphalia, Germany · Not yet recruiting
Klinikum Altenburger Land GmbH-Klinik für Kardiologie, Pneumologie und Internistische Intensivmedizin
Altenburg, Thuringia, Germany · Recruiting
Semmelweis Egyetem, Varosmajori Sziv- és Ergyogyaszati Klinika
Budapest, Hungary · Recruiting
Tolna Vármegyei Balassa János Kórház - I. Belgyógyászati Osztály: Kardiológia, Nefrológia
Szekszárd, Tolna County, Hungary · Not yet recruiting
Ente Ecclesiastico Ospedale Generale Regionale Miulli - Cardiologia e UTIC
Acquaviva delle Fonti, Apulia, Italy · Recruiting
Azienda Ospedaliero-Universitaria Policlinico Umberto I - Malattie Cardiovascolari
Rome, Lazio, Italy · Not yet recruiting
Centro Cardiologico Monzino S.p.A. - UO Scompenso e Cardiologia Clinica
Milan, Lombardy, Italy · Recruiting
Azienda Ospedaliero Universitaria Delle Marche - Clinica di Cardiologia e Aritmologia
Torrette, The Marches, Italy · Not yet recruiting
Universitair Medisch Centrum Groningen
Groningen, Netherlands · Not yet recruiting
Maastricht UMC
Maastricht, Limburg, Netherlands · Not yet recruiting
American Heart of Poland S.A. - MCSN, PAKS w Chrzanowie - Oddział Intensywnej Opieki Kardiologicznej
Chrzanów, Lesser Poland Voivodeship, Poland · Not yet recruiting
USK nr 4 w Lublinie - Kliniczny Odd. Kardiologii, Reh. Kardio., Ch. Wew. z Pododdzialem Intensywnej Opieki Kardio.
Lublin, Lublin Voivodeship, Poland · Not yet recruiting
Samodzielny Publiczny Specjalistyczny Szpital Zachodni im. sw. Jana Pawla II
Grodzisk Mazowiecki, Masovian Voivodeship, Poland · Recruiting
American Heart of Poland S.A. - PAKS Centrum Kardiologii i Kardiochirurgii w Bielsku-Białej - Oddział Kardiologii
Bielsko-Biala, Silesian Voivodeship, Poland · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.